Latest News

Immune-modulating drug unexpectedly benefits mice with fatal mitochondrial defect

In a lab devoted to increasing healthy lifespans, the transplant anti-rejection drug rapamycin showed unexpected health benefits and increased survival in a mouse model of a fatal mitochondrial defect. Children with the untreatable condition suffer from brain damage and muscle weakness, and rarely live beyond 6 or 7 years. The drug enables the body to bypass the mitochondrial defect by switching its metabolism to burn fats and amino acids instead of glucose, and thereby reduces toxic byproducts.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Scientists discover link between common medications and serious falls in older men

  • Sleepy fruitflies get mellow

  • Research grasps how brain plans gripping motion

  • How to digitally stoke that old-time auction fever

  • Autism costs estimated to reach nearly 0 billion, potentially trillion, by 2025

  • Coffee consumption habits impact the risk of mild cognitive impairment

  • Very early birth linked to introversion, neuroticism, risk aversion in adulthood

  • Where memory is encoded and retrieved: New findings in a long-standing debate

  • Neurology researchers evaluate evidence base for tests for clinical cognitive assessment

  • Majority rule: Why conformity can actually be a good thing

  •